Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Alzamend Neuro, Inc. (ALZN)
:ALZN
Holding ALZN?
Track your performance easily
ALZN Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.06 - $15.06
Previous Close$1.15
Volume144.13K
Average Volume (3M)153.19K
Market Cap
$6.25M
Enterprise ValueN/A
Total Cash (Recent Filing)$90.28K
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.26
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-6.65
Shares Outstanding5,432,797
10 Day Avg. Volume99,340
30 Day Avg. Volume153,191
Standard Deviation0.21
R-Squared0.00024
Alpha-0.13
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$32.00Price Target Upside2682.61% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Alzamend Neuro News
PremiumCompany Announcements
Alzamend Neuro Regains Nasdaq Compliance After Strategic Appeal
Ownership Overview
3.57% Insiders
0.33% Mutual Funds
<0.01% Other Institutional Investors
95.95% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
ALZN FAQ
What was Alzamend Neuro, Inc.’s price range in the past 12 months?
Alzamend Neuro, Inc. lowest stock price was $1.06 and its highest was $15.06 in the past 12 months.
What is Alzamend Neuro, Inc.’s market cap?
Alzamend Neuro, Inc.’s market cap is $6.25M.
When is Alzamend Neuro, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Alzamend Neuro, Inc.’s earnings last quarter?
Alzamend Neuro, Inc. released its earnings results on Mar 15, 2022. The company reported -$4.5 earnings per share for the quarter, the consensus estimate of -$4.5 by $0.
Is Alzamend Neuro, Inc. overvalued?
According to Wall Street analysts Alzamend Neuro, Inc.’s price is currently Undervalued.
Does Alzamend Neuro, Inc. pay dividends?
Alzamend Neuro, Inc. does not currently pay dividends.
What is Alzamend Neuro, Inc.’s EPS estimate?
Alzamend Neuro, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Alzamend Neuro, Inc. have?
Alzamend Neuro, Inc. has 5,432,797 shares outstanding.
What happened to Alzamend Neuro, Inc.’s price movement after its last earnings report?
Alzamend Neuro, Inc. reported an EPS of -$4.5 in its last earnings report, expectations of -$4.5. Following the earnings report the stock price went down -4.798%.
Which hedge fund is a major shareholder of Alzamend Neuro, Inc.?
Currently, no hedge funds are holding shares in ALZN
---
Company Description
Alzamend Neuro, Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders. Its pipeline of product candidates consist of two novel therapeutic drug candidates namely AL001 a patented ionic co-crystal technology delivering a therapeutic combination of lithium, proline and salicylate, and; AL002 a patented method using a mutant peptide sensitized cell as a cell-based therapeutic vaccine that reduces beta-amyloid plaque and seeks to restore the ability of the patient's immunological system to combat Alzheimer's.
---
ALZN Stock 12 Month Forecast
Average Price Target
$32.00
▲(2682.61% Upside)
Technical Analysis
Anavex Life Sciences
―
Cassava Sciences
―
Annovis Bio
―
Inmune Bio
―
Athira Pharma
―
AC Immune SA
―
Best Analysts Covering ALZN
1 Year
1 Year Success Rate
0/11 ratings generated profit
1 Year Average Return
-69.40%
reiterated a buy rating last month
Copying Edward Woo's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -69.40% per trade.
---